Patent Assignment
Reel/Frame 067609/0031
Assignment of Assignor's Interest
Recorded: 2024-06-04
Pages: 8
Assignor
ASPA THERAPEUTICS, INC.
Executed: 2024-04-04
Assignee
BRIDGEBIO GENE THERAPY LLC
1800 OWENS STREET, C-1200, SAN FRANCISCO, CALIFORNIA, 94158
Covered Property
(1)
Methods and Compositions for Treating Leukodystrophies
Application:
18/700,508 →
Publication:
US 2026/0048146
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 4, 2024
From: LAFORET, GENEVIEVE; SHAYWITZ, ADAM; KIRBY, KATHLEEN M.
To: BRIDGEBIO SERVICES INC.
Reel/Frame 067608/0887 →
Assignment of Assignor's Interest
Jun 4, 2024
From: BRIDGEBIO SERVICES INC.
To: ASPA THERAPEUTICS, INC.
Reel/Frame 067608/0968 →
Security Interest
Jun 28, 2024
From: BRIDGEBIO PHARMA, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION
Reel/Frame 067870/0874 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0120 →